Whether you need to continue taking Capecitabine after chemotherapy for breast cancer should be chosen according to the effect of chemotherapy, physical status and doctor’s advice. Capecitabine is usually used in the treatment of colon cancer, breast cancer and other types of cancer chemotherapy treatment, can effectively target the cancer cells to kill, so as to control the growth and metastasis of cancer cells. Adverse effects such as nausea, vomiting, abdominal pain, dullness of sensation or mucositis may occur during use. Therefore, it is contraindicated in people who are allergic to the drug and in women during pregnancy. Children and breastfeeding women need to use with caution. After the completion of chemotherapy for breast cancer, capecitabine can be taken as a consolidation course of treatment, which can effectively prevent the recurrence and metastasis of breast cancer. However, if the cancer cells are basically killed and the patient’s body recovers well after chemotherapy, and the results of immunohistochemistry and other biochemical tests are negative, then there is no need to continue taking capecitabine. Breast cancer patients are advised to consult the doctor’s advice to choose whether to continue to take chemotherapy drugs after the completion of chemotherapy, do not take drugs without authorization.